Literature DB >> 20126294

Phenylketonuria in Children and Mothers: Genes, Environments, Behavior.

Keith F Widaman1.   

Abstract

Phenylketonuria (PKU) is an inborn metabolic error in which metabolism of phenylalanine into tyrosine is disrupted. If the diet of an infant with PKU is not restricted, blood phenylalanine levels are elevated, leading to irremediable brain damage and severe mental retardation. Children with PKU who are placed early and continuously on a low-phenylalanine diet develop normal levels of intelligence, and brain damage is largely prevented. However, if the diet of a mother with PKU is unrestricted during her pregnancy, high phenylalanine levels in her blood can cross the placental barrier and damage the developing fetus in multiple ways. These results demonstrate how genes and environmental factors combine to create prenatal environments that can have profound effects on the growth and development of offspring during infancy and childhood.

Entities:  

Year:  2009        PMID: 20126294      PMCID: PMC2705125          DOI: 10.1111/j.1467-8721.2009.01604.x

Source DB:  PubMed          Journal:  Curr Dir Psychol Sci        ISSN: 0963-7214


  8 in total

1.  The effect of a phenylalanine-restricted diet on phenylketonuria.

Authors:  P Burgard; R Link; S Schweitzer-Krantz
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

Review 2.  Phenylketonuria (PKU): screening and management.

Authors: 
Journal:  NIH Consens Statement       Date:  2000 Oct 16-18

3.  Phenylketonuria in adulthood: a collaborative study.

Authors:  R Koch; B Burton; G Hoganson; R Peterson; W Rhead; B Rouse; R Scott; J Wolff; A M Stern; F Guttler; M Nelson; F de la Cruz; J Coldwell; R Erbe; M T Geraghty; C Shear; J Thomas; C Azen
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  Survey of national guidelines for the treatment of phenylketonuria.

Authors:  S Schweitzer-Krantz; P Burgard
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

5.  Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.

Authors:  A Diamond; M B Prevor; G Callender; D P Druin
Journal:  Monogr Soc Res Child Dev       Date:  1997

6.  Role of genotype in the cycle of violence in maltreated children.

Authors:  Avshalom Caspi; Joseph McClay; Terrie E Moffitt; Jonathan Mill; Judy Martin; Ian W Craig; Alan Taylor; Richie Poulton
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

7.  Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.

Authors:  Keith F Widaman; Colleen Azen
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

8.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

  8 in total
  2 in total

Review 1.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

2.  From observational to dynamic genetics.

Authors:  Claire M A Haworth; Oliver S P Davis
Journal:  Front Genet       Date:  2014-01-21       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.